Thu Feb 05 15:05:38 UTC 2026: ### BioAsia 2026 to Focus on AI and Biotechnology Convergence in Hyderabad

The Story:
Chief Minister A. Revanth Reddy will inaugurate BioAsia 2026 in Hyderabad on February 17. The 23rd edition of this annual life sciences and health-tech forum will center on the theme “TechBio Unleashed: AI, Automation and the Biology Revolution.” The two-day event aims to bring together policymakers, global biotech and pharma leaders from companies like Amgen, Sanofi, and Eli Lilly, and regulators. Union Ministers Piyush Goyal and Ashwini Vaishnaw, along with Telangana IT and Industries Minister D. Sridhar Babu, are also slated to participate.

The conference will feature keynote addresses from prominent figures like Bruce L. Levine, Professor of Cancer Gene Therapy at the University of Pennsylvania, and Howard Y. Chang, Chief Scientific Officer of Amgen. Sessions will explore the convergence of AI, advanced biology, and intelligent manufacturing and their transformative impact on therapy discovery, development, and delivery. A special session on “Telangana Rising Vision 2047” will outline the state’s roadmap for innovation-led growth in these sectors.

Key Points:

  • BioAsia 2026, a leading life sciences and health-tech forum, will be held in Hyderabad starting February 17.
  • The theme is “TechBio Unleashed: AI, Automation and the Biology Revolution,” focusing on the convergence of AI and biology.
  • Attendees include policymakers, global biotech and pharma leaders, and regulators.
  • Keynote speakers include leaders from academia (University of Pennsylvania) and major pharmaceutical companies (Amgen, Sanofi).
  • A dedicated session will focus on Telangana’s vision for innovation-led growth by 2047.

Key Takeaways:

  • Hyderabad is solidifying its position as a major hub for biotechnology and life sciences in Asia.
  • AI’s role in accelerating drug discovery and development is becoming increasingly important.
  • Telangana is actively pursuing a long-term strategy to capitalize on the intersection of technology and biology.
  • The participation of major global pharmaceutical companies underscores the significance of BioAsia as a platform for collaboration and investment.
  • The conference indicates a global trend towards integrating AI into all facets of healthcare, from research to manufacturing.

Impact Analysis:

This event signifies a strategic push for Telangana and India to become leaders in the TechBio space. By attracting major industry players and focusing on AI-driven innovation, BioAsia 2026 is poised to stimulate investment and create opportunities in the region. The long-term impact includes:

  • Economic Growth: Increased investment in biotechnology and related industries, leading to job creation and economic development in Telangana.
  • Innovation Ecosystem: Fostering a vibrant ecosystem for research and development, attracting talent and promoting scientific breakthroughs.
  • Healthcare Advancements: Accelerating the development and delivery of new therapies and diagnostic tools, improving healthcare outcomes both locally and globally.
  • Global Partnerships: Strengthening collaborations between Indian and international companies and institutions, facilitating knowledge transfer and technological advancements.
  • Policy Influence: Providing a platform for shaping policies that support the growth of the TechBio sector and promote innovation in healthcare.

    Read More

Related News: